Suppr超能文献

8. 肥胖与体重管理在2型糖尿病预防和治疗中的应用:2025年糖尿病照护标准

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025.

出版信息

Diabetes Care. 2025 Jan 1;48(Supplement_1):S167-S180. doi: 10.2337/dc25-S008.

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

摘要

美国糖尿病协会(ADA)的《糖尿病护理标准》包含了ADA当前的临床实践建议,旨在提供糖尿病护理的组成部分、一般治疗目标和指南,以及评估护理质量的工具。ADA专业实践委员会是一个跨专业专家委员会,其成员负责每年更新《护理标准》,如有必要,更新频率可更高。有关ADA标准、声明和报告的详细说明,以及ADA临床实践建议的证据分级系统和专业实践委员会成员的完整名单,请参阅“引言和方法”。欢迎希望对《护理标准》发表评论的读者访问professional.diabetes.org/SOC进行评论。

相似文献

2
7. Diabetes Technology: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S146-S166. doi: 10.2337/dc25-S007.
3
17. Diabetes Advocacy: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S335-S336. doi: 10.2337/dc25-S017.
4
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S321-S334. doi: 10.2337/dc25-S016.
5
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S27-S49. doi: 10.2337/dc25-S002.
6
14. Children and Adolescents: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S283-S305. doi: 10.2337/dc25-S014.
7
13. Older Adults: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S266-S282. doi: 10.2337/dc25-S013.
8
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S14-S26. doi: 10.2337/dc25-S001.
9
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S207-S238. doi: 10.2337/dc25-S010.
10
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S50-S58. doi: 10.2337/dc25-S003.

引用本文的文献

2
Mapping evidence and identifying risks: A systematic scoping review of meal replacements in type 2 diabetes.
World J Diabetes. 2025 Aug 15;16(8):104371. doi: 10.4239/wjd.v16.i8.104371.
4
Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment.
Nutrients. 2025 Jul 21;17(14):2382. doi: 10.3390/nu17142382.
6
Lifestyle Interventions in Cardiovascular-Kidney-Metabolic Syndrome JACC: Advances Expert Panel.
JACC Adv. 2025 Jun;4(6 Pt 2):101788. doi: 10.1016/j.jacadv.2025.101788.
10
Feasibility and Efficacy of a Plant-Based Nutrition Intervention for Type 2 Diabetes in a Primary Care Setting.
Am J Lifestyle Med. 2025 May 1:15598276251339396. doi: 10.1177/15598276251339396.

本文引用的文献

1
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies.
Diabetes Obes Metab. 2024 Sep;26 Suppl 4:16-27. doi: 10.1111/dom.15728. Epub 2024 Jun 27.
2
3
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943. Epub 2024 Jun 8.
5
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med. 2024 Apr 18;390(15):1394-1407. doi: 10.1056/NEJMoa2313917. Epub 2024 Apr 6.
8
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
9
Use and continuity of weight-modifying medications among adults with diabetes and overweight/obesity: US population study.
Obesity (Silver Spring). 2023 Dec;31(12):2924-2935. doi: 10.1002/oby.23869. Epub 2023 Nov 2.
10
Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study.
Surg Endosc. 2023 Dec;37(12):9509-9513. doi: 10.1007/s00464-023-10387-1. Epub 2023 Sep 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验